• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无黑色素瘤患者非前哨淋巴结受累,其局限型 Breslow 厚度和低前哨淋巴结肿瘤负荷。

No non-sentinel node involvement in melanoma patients with limited Breslow thickness and low sentinel node tumour load.

机构信息

Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Histopathology. 2011 Aug;59(2):318-26. doi: 10.1111/j.1365-2559.2011.03931.x.

DOI:10.1111/j.1365-2559.2011.03931.x
PMID:21884211
Abstract

AIMS

Most melanoma patients with a positive sentinel node (SN) undergo completion lymph node dissection and frequently experience associated morbidity. However, only 10-30% of SN-positive patients have further lymph node metastases. The aim of the present study was to predict the absence of non-SN metastases in a multicentre study of patients with a positive SN based on primary melanoma features and SN tumour load.

METHODS AND RESULTS

Of 70 SN positive patients, 18 had non-SN metastases. Penetrative depth of metastatic cells into the SN and SN tumour load was assessed by morphometry. None of the 14 patients (20%) with a Breslow thickness <2.0 mm and an SN tumour load <0.2 mm2 had non-SN metastases. Similarly, none of the 15 patients (21%) with a Breslow thickness <2.0 mm and SN penetrative depth <600 μm had non-SN metastases. Lastly, none of the 14 patients (20%) with a Breslow thickness <2.0 mm and a diameter of the largest SN deposit <500 μm had non-SN metastases.

CONCLUSIONS

A combination of limited Breslow thickness and low SN tumour load predicts absence of non-SN metastases in melanoma patients with a positive SN with high accuracy. We propose that this subgroup may be spared completion lymph node dissection.

摘要

目的

大多数有阳性前哨淋巴结(SN)的黑色素瘤患者接受完成淋巴结清扫术,并经常经历相关的发病率。然而,只有 10-30%的 SN 阳性患者有进一步的淋巴结转移。本研究的目的是基于原发性黑色素瘤特征和 SN 肿瘤负荷,在一项阳性 SN 患者的多中心研究中预测非 SN 转移的缺失。

方法和结果

在 70 例 SN 阳性患者中,18 例有非 SN 转移。通过形态计量学评估转移性细胞在 SN 中的穿透深度和 SN 肿瘤负荷。在 Breslow 厚度<2.0mm 和 SN 肿瘤负荷<0.2mm2 的 14 例患者中(20%),均无非 SN 转移。同样,在 Breslow 厚度<2.0mm 和 SN 穿透深度<600μm 的 15 例患者中(21%),均无非 SN 转移。最后,在 Breslow 厚度<2.0mm 和最大 SN 沉积物直径<500μm 的 14 例患者中(20%),均无非 SN 转移。

结论

有限的 Breslow 厚度和低 SN 肿瘤负荷的组合可以准确预测 SN 阳性黑色素瘤患者中不存在非 SN 转移。我们建议,这一亚组可能可以免于完成淋巴结清扫术。

相似文献

1
No non-sentinel node involvement in melanoma patients with limited Breslow thickness and low sentinel node tumour load.无黑色素瘤患者非前哨淋巴结受累,其局限型 Breslow 厚度和低前哨淋巴结肿瘤负荷。
Histopathology. 2011 Aug;59(2):318-26. doi: 10.1111/j.1365-2559.2011.03931.x.
2
Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma.前哨淋巴结肿瘤负荷:黑色素瘤中额外淋巴结受累及生存的独立预测因素。
Ann Surg Oncol. 2005 Jun;12(6):440-8. doi: 10.1245/ASO.2005.06.013. Epub 2005 Apr 19.
3
High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.欧洲癌症研究与治疗组织(EORTC)黑色素瘤研究组方案对前哨淋巴结的高阳性识别率。黑色素瘤前哨淋巴结活检后转移模式的预后指标。
Eur J Cancer. 2006 Feb;42(3):372-80. doi: 10.1016/j.ejca.2005.10.023. Epub 2006 Jan 5.
4
Value of micromorphometric criteria of sentinel lymph node metastases in predicting further nonsentinel lymph node metastases in patients with melanoma.前哨淋巴结转移的微形态学标准对预测黑色素瘤患者进一步非前哨淋巴结转移的价值。
Melanoma Res. 2011 Apr;21(2):139-43. doi: 10.1097/CMR.0b013e328343ecf4.
5
Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours.黑素细胞肿瘤患者管理中淋巴绘图与前哨淋巴结活检的最新进展
Pathology. 2004 Oct;36(5):478-84. doi: 10.1080/00313020412331282726.
6
EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria.EORTC 黑色素瘤组前哨淋巴结协议根据鹿特丹标准确定了高亚毫米转移率。
Eur J Cancer. 2010 Sep;46(13):2414-21. doi: 10.1016/j.ejca.2010.06.003.
7
[Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].[前哨淋巴结活检对恶性黑色素瘤患者的重要预后意义]
Ned Tijdschr Geneeskd. 2004 May 1;148(18):884-8.
8
Reevaluation of the locoregional recurrence rate in melanoma patients with a positive sentinel node compared to patients with palpable nodal involvement.与可触及淋巴结受累的患者相比,前哨淋巴结阳性的黑色素瘤患者的局部区域复发率的再评估。
Ann Surg Oncol. 2010 Feb;17(2):521-6. doi: 10.1245/s10434-009-0776-y. Epub 2009 Nov 7.
9
The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).前哨淋巴结黑色素瘤阳性患者在完成淋巴结清扫术后的生存获益可能仅限于原发灶Breslow厚度大于1.0且小于或等于4mm(pT2-pT3)的亚组。
Ann Surg Oncol. 2008 Aug;15(8):2223-34. doi: 10.1245/s10434-008-9965-3. Epub 2008 May 28.
10
Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.对黑色素瘤患者前哨淋巴结活检或治疗性淋巴结清扫术后的结局进行多变量分析。
Br J Surg. 2007 Oct;94(10):1293-9. doi: 10.1002/bjs.5814.

引用本文的文献

1
SLN melanoma micrometastasis predictivity of nodal status: a long term retrospective study.SLN 黑色素瘤微转移对淋巴结状态的预测性:一项长期回顾性研究。
J Exp Clin Cancer Res. 2013 Aug 1;32(1):47. doi: 10.1186/1756-9966-32-47.